IN2014DN11097A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN11097A IN2014DN11097A IN11097DEN2014A IN2014DN11097A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A IN 11097DEN2014 A IN11097DEN2014 A IN 11097DEN2014A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A
- Authority
- IN
- India
- Prior art keywords
- particles
- titanium
- micrometer
- cavities
- exhibit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention describes particles of titanium titanium alloy at least one type of titanium oxide or a combination thereof wherein at least a substantial amount of the particles are of micrometer millimeter size and are non spherical for use as an X ray contrast agent. The irregular shapes and/or internal pores and cavities of said particles lead to a prolonged retention time in the gastrointestinal tract leading to a longer time period available for X ray examination. Further the particles are not only chemically inert they also exhibit an anti inflammatory and anti bacterial effect on the surrounding tissue.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261655093P | 2012-06-04 | 2012-06-04 | |
SE1250582 | 2012-06-04 | ||
PCT/SE2013/050620 WO2013184061A1 (en) | 2012-06-04 | 2013-05-29 | Medical use of particles of titanium and/or titanium oxide |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN11097A true IN2014DN11097A (en) | 2015-09-25 |
Family
ID=49712337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN11097DEN2014 IN2014DN11097A (en) | 2012-06-04 | 2013-05-29 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150139913A1 (en) |
EP (1) | EP2854868A4 (en) |
CN (1) | CN104736184A (en) |
IN (1) | IN2014DN11097A (en) |
WO (1) | WO2013184061A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2897624T3 (en) * | 2013-03-15 | 2022-03-02 | Univ California | Low-z Atom-Based Enteric CT Contrast Material |
CN113456839B (en) * | 2021-07-05 | 2022-06-21 | 浙江大学 | Dipole resonance enhanced double-negative acoustic metamaterial and application thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4020152A (en) * | 1973-12-18 | 1977-04-26 | Thann & Mulhouse | Barium titanate and barium zirconate in radiological contrast products |
EP0253554A3 (en) * | 1986-07-15 | 1988-07-20 | Pfizer Inc. | Controlled release drug-containing fibers |
GB9204388D0 (en) * | 1992-02-29 | 1992-04-15 | Tioxide Specialties Ltd | Water-in-oil emulsions |
US5593657A (en) * | 1995-02-09 | 1997-01-14 | Nanosystems L.L.C. | Barium salt formulations stabilized by non-ionic and anionic stabilizers |
US6024569A (en) * | 1998-11-06 | 2000-02-15 | Aytec Japan Corporation | Root canal filling point |
SE515227C2 (en) * | 1999-04-28 | 2001-07-02 | Bruce Medical Ab | Body for providing and growing bone and / or connective tissue and methods for making the body |
DE10018405B4 (en) * | 2000-04-13 | 2004-07-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Spherical oxidic particles and their use |
US6394965B1 (en) * | 2000-08-15 | 2002-05-28 | Carbon Medical Technologies, Inc. | Tissue marking using biocompatible microparticles |
AU2003226688B2 (en) * | 2002-03-22 | 2009-08-13 | Kuros Biosurgery Ag | Composition for hard tissue augmentation |
US8012454B2 (en) * | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
JP4474878B2 (en) * | 2003-09-17 | 2010-06-09 | 株式会社Ihi | X-ray contrast medium and method for producing X-ray contrast medium |
JP2008518873A (en) * | 2004-11-02 | 2008-06-05 | ナノゲート エージー | Synthesis of titanium dioxide nanoparticles |
SE531318C2 (en) * | 2007-02-22 | 2009-02-24 | Tigran Technologies Ab Publ | Injectable suspension comprising microstructure titanium titanium, titanium alloy or titanium oxide particles |
JP2008297289A (en) * | 2007-06-04 | 2008-12-11 | Canon Inc | Contrast medium and production method thereof |
EP2344569B1 (en) * | 2008-09-30 | 2019-03-13 | SABIC Global Technologies B.V. | X-ray and/or metal detectable articles and method of making the same |
GB0921596D0 (en) * | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
WO2011084625A1 (en) * | 2009-12-16 | 2011-07-14 | Georgia Tech Research Corporation | Systems and methods for x-ray flourescence computed tomography imaging with nanoparticles |
-
2013
- 2013-05-29 IN IN11097DEN2014 patent/IN2014DN11097A/en unknown
- 2013-05-29 CN CN201380029110.4A patent/CN104736184A/en active Pending
- 2013-05-29 WO PCT/SE2013/050620 patent/WO2013184061A1/en active Application Filing
- 2013-05-29 EP EP13799808.4A patent/EP2854868A4/en not_active Withdrawn
- 2013-05-29 US US14/405,489 patent/US20150139913A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2854868A1 (en) | 2015-04-08 |
US20150139913A1 (en) | 2015-05-21 |
WO2013184061A1 (en) | 2013-12-12 |
EP2854868A4 (en) | 2016-01-20 |
CN104736184A (en) | 2015-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2865972C (en) | Inhalable dry powders | |
IL255113A0 (en) | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | |
IL223889B (en) | Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects | |
EP3861982A3 (en) | Intracameral implant for treatment of an ocular condition | |
MX2019000225A (en) | Compositions and methods for treatment of autoimmune and other disease. | |
IL234101B (en) | Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism | |
EP3686184A3 (en) | Ionizable compounds and compositions and uses thereof | |
IN2014DN08882A (en) | ||
HK1222562A1 (en) | Compositions and methods for use in medical diagnosis | |
BR112012004967A2 (en) | oral dosage form comprising at least one biologically active agent, formulation aids and magnetizable particles | |
WO2012138379A3 (en) | Multifunctional chelator-free radioactive nanoparticles for imaging and therapy | |
EP3052191A4 (en) | Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als) | |
HRP20170987T1 (en) | Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states | |
JP2012528941A5 (en) | ||
PT2523674E (en) | Compositions comprising andrographis paniculata extracts combined with ginkgo biloba extracts complexed with phospholipids, and their use | |
MX2016005092A (en) | Vaginal inserted estradiol pharmaceutical compositons and methods. | |
IN2014DN11097A (en) | ||
WO2015054208A8 (en) | Injectable compositions | |
PT2603238E (en) | Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject | |
MX2018004445A (en) | Colloidal particles for use in medicine. | |
EP3906931A3 (en) | Use of immune suppressive domains as medicaments | |
WO2014031982A3 (en) | Methods and compositions for treating pain | |
AR090586A1 (en) | NANOPARTICULES SUPPORTED ON AMORFO CARBON THAT INCLUDE OXIDES OF LANTANIDS AND METHOD FOR PREPARATION | |
LT2988792T (en) | Pharmaceutical compositions containing hyaluronic acid for use in the treatment of black disk disease | |
WO2013131998A3 (en) | Vegetal material -based compositions comprising hydrophilic and lipophilic complexes |